Y Intercept (Hong Kong) LTD Integra Lifesciences Holdings Corp Transaction History

Y Intercept (Hong Kong) LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$33.4 - $45.2 $225,817 - $305,597	6,761 Added 34.54%	26,333 $933,000
Q4 2023 Feb 13, 2024	BUY	$34.21 - $44.59 $669,558 - $872,715	19,572 New	19,572 $852,000
Q2 2023 Aug 14, 2023	BUY	$37.95 - $58.98 $68,196 - $105,987	1,797 Added 19.86%	10,846 $446,000
Q1 2023 May 09, 2023	BUY	$52.61 - $60.49 $197,287 - $226,837	3,750 Added 70.77%	9,049 $519,000
Q4 2022 Feb 14, 2023	SELL	$42.17 - $58.6 $795,621 - $1.11 Million	-18,867 Reduced 78.07%	5,299 $297,000
Q3 2022 Feb 14, 2023	BUY	$42.28 - $57.17 $294,945 - $398,817	6,976 Added 40.58%	24,166 $1.02 Million
Q2 2022 Aug 08, 2022	BUY	$53.86 - $66.52 $214,793 - $265,281	3,988 Added 30.21%	17,190 $929,000
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $472,518 - $520,477	7,517 Added 132.23%	13,202 $848,000
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $355,141 - $416,426	5,685 New	5,685 $381,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.